Researchers have developed a computer program which has revealed a previously unknown combination of drugs that may be the answer to Triple Negative Breast Cancer (TNBC), using genetic and treatment data from TNBC cells grown in labs and from hundreds of patients world-wide. Importantly researchers can tell, by inputting patients’ genomic and proteomic information into their computer model, who may benefit from this drug combination or not — saving precious time.